Physicochemical Properties
| Molecular Formula | C9H17NO |
| Molecular Weight | 155.2374 |
| Exact Mass | 155.131 |
| CAS # | 826-36-8 |
| Related CAS # | Triacetonamine monohydrate;10581-38-1;Triacetonamine-d17;52168-48-6 |
| PubChem CID | 13220 |
| Appearance | Brown to reddish brown <34°C powder,>38°C liquid |
| Density | 0.9±0.1 g/cm3 |
| Boiling Point | 205.6±15.0 °C at 760 mmHg |
| Melting Point | 59-61 °C |
| Flash Point | 73.2±20.5 °C |
| Vapour Pressure | 0.2±0.4 mmHg at 25°C |
| Index of Refraction | 1.427 |
| LogP | 1.32 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Heavy Atom Count | 11 |
| Complexity | 164 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | O=C1CC(C)(C)NC(C)(C)C1 |
| InChi Key | JWUXJYZVKZKLTJ-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C9H17NO/c1-8(2)5-7(11)6-9(3,4)10-8/h10H,5-6H2,1-4H3 |
| Chemical Name | 2,2,6,6-tetramethylpiperidin-4-one |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. Triacetonamine formation in a bio-oil from fast pyrolysis of sewage sludge using acetone as the absorption solvent. Bioresour Technol. 2010 Jun;101(11):4242-5. [2]. Application of Bone Marrow Mesenchymal Stem Cells Effectively Eliminates Endotoxemia to Protect Rat from Acute Liver Failure Induced by Thioacetamide. Tissue Eng Regen Med. 2022 Apr;19(2):403-415. |
| Additional Infomation |
Triacetonamine is a member of piperidones. 2,2,6,6-Tetramethyl-4-piperidone has been reported in Caroxylon tetrandrum and Agelas oroides with data available. |
Solubility Data
| Solubility (In Vitro) | Ethanol : ~50 mg/mL (~322.08 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (16.10 mM) (saturation unknown) in 10% EtOH + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear EtOH stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (16.10 mM) (saturation unknown) in 10% EtOH + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear EtOH stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (16.10 mM) (saturation unknown) in 10% EtOH + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear EtOH stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 6.4416 mL | 32.2082 mL | 64.4164 mL | |
| 5 mM | 1.2883 mL | 6.4416 mL | 12.8833 mL | |
| 10 mM | 0.6442 mL | 3.2208 mL | 6.4416 mL |